Business Standard

Shukra Pharmaceuticals Share Price

Know More

89.45-1.80 (-1.97%)

04:01 PM,15th Jul 2024
Stock not traded

BSE : 524632


Sector : Health care

ISIN Code : INE551C01028

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 15-Jul-2024 | 04:01 PM IST

Market Cap (₹ Cr)


Turnover (₹ Cr)


Volume (Shares)


Face Value


52-WK High


52-WK High Date


52-WK Low


52-WK Low Date


All Time High


All Time High Date


All Time Low


All Time Low Date


Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd (Formerly known Relish Pharmaceuticals Limited) was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September 2016. The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin) Anti Biotics (Cephalosporin) Anti Biotics Macrolides Quinolones Anti Bacterial Anti Fungal Anti Malarial Anti Viral Anti Protozoal Anti Anthelmintic Sedative and Tranquilliser Anti Depressant Anti Manic Anti Em...
Read More

Shukra Pharma. Announcement

View More

Shukra Pharmaceuticals Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [S]


P/E Ratio (X) [S]


Face Value (₹) 10
Latest Dividend (%)5.00
Latest Dividend Date 15-Sep-2023
Dividend Yield (%) 0.28
Book Value Share (₹) [S]13.16
P/B Ratio (₹) [S]6.80

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

Date Broker Action Prices(₹) Report
Data Not Found

Stock Strength

Today's Low/High



Week Low/High



Month Low/High



Year Low/High



All time Low/High



Share Price Returns

1 Week-9.51%%0.881.09%
1 Month-23.09%%4.774.78%
3 Month11.98%%9.9010.39%
6 Month162.70%%10.0111.26%
1 Year%%22.1125.67%
3 Year2594.28%%51.7454.40%

Company Info

Company Information

Chairman & Managing Director : Dakshesh Shah

Executive Director : Payal Mehta

Independent Director : Bhoomiben Patel

Independent Director : Sarjeevan Singh

Independent Director : Sonal Deepalbhai Gandhi

Executive Director : Sanskruti Patel

Executive Director : Dhruvin Shah

Independent Director : Pinki Nirmal Sagar

Registered Office: 3 rd Floor Dev House, Opp WIAA Office Judges Bungalo,Ahmedabad,Gujarat-380054 Ph: 91-079-66522247/27498515


FAQs about Shukra Pharmaceuticals Ltd

1. What's the Shukra Pharmaceuticals Ltd share price today?
Shukra Pharmaceuticals Ltd share price was Rs 89.45 at 04:01 PM IST on 15th Jul 2024. Shukra Pharmaceuticals Ltd share price was down by 1.97% from the previous closing price of Rs 91.25. Shukra Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Shukra Pharmaceuticals Ltd share price moved down by 23.09% on BSE
  • Last 3 Months: Shukra Pharmaceuticals Ltd share price moved up by 11.98% on BSE
  • Last 12 Months: Shukra Pharmaceuticals Ltd share price moved up by % on BSE
  • Last 3 Years: Shukra Pharmaceuticals Ltd price moved up by 2594.28% on BSE

2. How can I quickly analyse the performance of the Shukra Pharmaceuticals Ltd stock?
The performance of the Shukra Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 21.15
  • Price to book value ratio is 6.80
  • Dividend yield of 0.28
  • The EPS (trailing 12 months) of the Shukra Pharmaceuticals Ltd stock is Rs 4.23

3. What is the market cap of Shukra Pharmaceuticals Ltd?
Shukra Pharmaceuticals Ltd has a market capitalisation of Rs 392 crore.

4. What is Shukra Pharmaceuticals Ltd's 52-week high/low share price?
The Shukra Pharmaceuticals Ltd’s 52-week high share price is Rs 129.90 and 52-week low share price is Rs 20.43.

5. Is the Shukra Pharmaceuticals Ltd profitable?
On a consolidated basis, Shukra Pharmaceuticals Ltd reported a profit of Rs 3.99 crore on a total income of Rs 12.26 crore for the quarter ended 2024. For the year ended Mar 2024, Shukra Pharmaceuticals Ltd had posted a profit of Rs 3.99 crore on a total income of Rs 12.26 crore.

6. Which are Shukra Pharmaceuticals Ltd’s peers in the Health care sector?
Shukra Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Zenotech Lab., Fredun Pharma, Lyka Labs, Shukra Pharma., Jenburkt Pharma, Kerala Ayurveda, Trident Lifeline.

7. Who owns how much in Shukra Pharmaceuticals Ltd?
Key changes to the Shukra Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Shukra Pharmaceuticals Ltd has gone up to 50.96 per cent as of Mar 2024 from 50.90 per cent as of Aug 2023.